2024 Q1 Form 10-Q Financial Statement

#000077954424000017 Filed on February 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $42.26M $47.49M
YoY Change 1.28%
Cost Of Revenue $12.14M $12.07M
YoY Change -7.41%
Gross Profit $30.12M $35.42M
YoY Change 4.63%
Gross Profit Margin 71.28% 74.58%
Selling, General & Admin $24.43M $26.63M
YoY Change 4.33%
% of Gross Profit 81.1% 75.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.057M $1.092M
YoY Change 3.8%
% of Gross Profit 3.51% 3.08%
Operating Expenses $31.32M $33.81M
YoY Change 4.28%
Operating Profit -$1.202M $1.603M
YoY Change 12.57%
Interest Expense $161.0K $171.0K
YoY Change -156.07%
% of Operating Profit 10.67%
Other Income/Expense, Net -$150.0K $151.0K
YoY Change 308.11%
Pretax Income -$1.352M $1.754M
YoY Change 51.73%
Income Tax -$147.0K $158.0K
% Of Pretax Income 9.01%
Net Earnings -$1.449M $1.370M
YoY Change 79.79%
Net Earnings / Revenue -3.43% 2.89%
Basic Earnings Per Share -$0.40 $0.38
Diluted Earnings Per Share -$0.40 $0.38
COMMON SHARES
Basic Shares Outstanding 3.604M shares 3.604M shares
Diluted Shares Outstanding 3.604M shares 3.631M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.41M $12.12M
YoY Change -57.41%
Cash & Equivalents $10.41M $12.12M
Short-Term Investments
Other Short-Term Assets $2.895M $1.368M
YoY Change -58.56%
Inventory $2.362M $2.972M
Prepaid Expenses
Receivables $4.042M $4.632M
Other Receivables $292.0K $306.0K
Total Short-Term Assets $20.00M $21.40M
YoY Change -45.26%
LONG-TERM ASSETS
Property, Plant & Equipment $32.84M $33.52M
YoY Change -3.34%
Goodwill $7.440M $7.440M
YoY Change -57.34%
Intangibles $4.220M $4.220M
YoY Change 0.0%
Long-Term Investments $6.528M $6.518M
YoY Change 0.82%
Other Assets $2.161M $2.161M
YoY Change -14.38%
Total Long-Term Assets $149.5M $152.2M
YoY Change -10.73%
TOTAL ASSETS
Total Short-Term Assets $20.00M $21.40M
Total Long-Term Assets $149.5M $152.2M
Total Assets $169.6M $173.6M
YoY Change -17.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.538M $4.573M
YoY Change 2.4%
Accrued Expenses $15.08M $16.48M
YoY Change -10.0%
Deferred Revenue $5.463M $3.418M
YoY Change -38.24%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.946M $2.011M
YoY Change -69.41%
Total Short-Term Liabilities $27.03M $26.48M
YoY Change -24.09%
LONG-TERM LIABILITIES
Long-Term Debt $4.227M $4.649M
YoY Change -72.8%
Other Long-Term Liabilities $88.23M $90.14M
YoY Change -7.49%
Total Long-Term Liabilities $92.45M $94.79M
YoY Change -17.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.03M $26.48M
Total Long-Term Liabilities $92.45M $94.79M
Total Liabilities $119.5M $121.3M
YoY Change -18.84%
SHAREHOLDERS EQUITY
Retained Earnings $34.66M $36.79M
YoY Change -16.91%
Common Stock $15.03M $14.97M
YoY Change -3.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.69M $51.75M
YoY Change
Total Liabilities & Shareholders Equity $169.6M $173.6M
YoY Change -17.17%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.449M $1.370M
YoY Change 79.79%
Depreciation, Depletion And Amortization $1.057M $1.092M
YoY Change 3.8%
Cash From Operating Activities $208.0K $558.0K
YoY Change -87.63%
INVESTING ACTIVITIES
Capital Expenditures $356.0K $276.0K
YoY Change -130.13%
Acquisitions
YoY Change
Other Investing Activities $14.00K $22.00K
YoY Change -100.43%
Cash From Investing Activities -$342.0K -$254.0K
YoY Change -95.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -1.576M -$1.597M
YoY Change -5.33%
NET CHANGE
Cash From Operating Activities 208.0K $558.0K
Cash From Investing Activities -342.0K -$254.0K
Cash From Financing Activities -1.576M -$1.597M
Net Change In Cash -1.710M -$1.293M
YoY Change -59.12%
FREE CASH FLOW
Cash From Operating Activities $208.0K $558.0K
Capital Expenditures $356.0K $276.0K
Free Cash Flow -$148.0K $282.0K
YoY Change -94.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47487000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47445000 usd
CY2023Q4 us-gaap Salaries And Wages
SalariesAndWages
16977000 usd
CY2022Q4 us-gaap Salaries And Wages
SalariesAndWages
16522000 usd
CY2023Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6092000 usd
CY2022Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5932000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3320000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3137000 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1092000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1033000 usd
CY2023Q4 us-gaap Costs And Expenses
CostsAndExpenses
45884000 usd
CY2022Q4 us-gaap Costs And Expenses
CostsAndExpenses
45242000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1603000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2203000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
171000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
429000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
11000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
90000 usd
CY2023Q4 us-gaap Other Income
OtherIncome
26000 usd
CY2022Q4 us-gaap Other Income
OtherIncome
0 usd
CY2023Q4 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
285000 usd
CY2022Q4 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
272000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
151000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-67000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1754000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2136000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
1596000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
2022000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
226000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
297000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1370000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1725000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3604000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3631000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3648000 shares
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51722000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
1596000 usd
CY2023Q4 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
0 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77000 usd
CY2023Q4 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
441000 usd
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1875
CY2023Q4 us-gaap Dividends Common Stock
DividendsCommonStock
676000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
52278000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60118000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
2022000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
79000 usd
CY2022Q4 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
120000 usd
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.000
CY2022Q4 us-gaap Dividends Common Stock
DividendsCommonStock
450000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61649000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
2022000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
77000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
79000 usd
CY2023Q4 arkr Paycheck Protection Program Loan Forgiveness Income Cash Received
PaycheckProtectionProgramLoanForgivenessIncomeCashReceived
0 usd
CY2022Q4 arkr Paycheck Protection Program Loan Forgiveness Income Cash Received
PaycheckProtectionProgramLoanForgivenessIncomeCashReceived
272000 usd
CY2023Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
28000 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9000 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1092000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1033000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
96000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
311000 usd
CY2023Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
13000 usd
CY2022Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1319000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1003000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-121000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-254000 usd
CY2023Q4 arkr Increase Decrease In Prepaid And Accrued Income Taxes
IncreaseDecreaseInPrepaidAndAccruedIncomeTaxes
-106000 usd
CY2022Q4 arkr Increase Decrease In Prepaid And Accrued Income Taxes
IncreaseDecreaseInPrepaidAndAccruedIncomeTaxes
-103000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-307000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-268000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-10000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
515000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
280000 usd
CY2023Q4 arkr Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
-2063000 usd
CY2022Q4 arkr Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
-3975000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
558000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-903000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
276000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
797000 usd
CY2023Q4 arkr Loans And Advances Made To Employees
LoansAndAdvancesMadeToEmployees
10000 usd
CY2022Q4 arkr Loans And Advances Made To Employees
LoansAndAdvancesMadeToEmployees
14000 usd
CY2023Q4 arkr Payments Received On Employee Receivables
PaymentsReceivedOnEmployeeReceivables
32000 usd
CY2022Q4 arkr Payments Received On Employee Receivables
PaymentsReceivedOnEmployeeReceivables
60000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-254000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-751000 usd
CY2023Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
480000 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1257000 usd
CY2023Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2022Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
531000 usd
CY2023Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
676000 usd
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
450000 usd
CY2023Q4 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
441000 usd
CY2022Q4 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
120000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1597000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2358000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1293000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4012000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13415000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23439000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12122000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19427000 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
158000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
416000 usd
CY2023Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
25000 usd
CY2022Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000 usd
CY2023Q4 arkr Noncash Decrease In Noncontrolling Interest From Deconsolidation
NoncashDecreaseInNoncontrollingInterestFromDeconsolidation
692000 usd
CY2022Q4 arkr Noncash Decrease In Noncontrolling Interest From Deconsolidation
NoncashDecreaseInNoncontrollingInterestFromDeconsolidation
0 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES — The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The accounting estimates that require management’s most difficult and subjective judgments include: projected cash flows, allowances for potential bad debts on receivables, assumptions regarding discount rates related to lease accounting, the useful lives and recoverability of its long-lived assets, such as property, right-of-use assets and intangibles, fair values of financial instruments and share-based compensation, estimates made in connection with acquisitions and impairment analyses, the realizable value of its tax assets and determining when investment impairments are other-than-temporary. Because of the uncertainty in such estimates, actual results may differ from these estimates. The results of operations for the 13 weeks ended December 30, 2023 are not necessarily indicative of the results to be expected for any other interim period or for the year ending September 28, 2024.</span></div>
CY2023Q4 arkr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
79284000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
138775000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
40502000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
98273000 usd
CY2022Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3418000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5962000 usd
CY2023Q4 arkr Liability For Gift Cards Included In Accrued Expenses And Other Current Liabilities
LiabilityForGiftCardsIncludedInAccruedExpensesAndOtherCurrentLiabilities
513000 usd
CY2023Q3 arkr Liability For Gift Cards Included In Accrued Expenses And Other Current Liabilities
LiabilityForGiftCardsIncludedInAccruedExpensesAndOtherCurrentLiabilities
340000 usd
CY2023Q4 arkr Number Of Vi Es With Primary Benefits
NumberOfVIEsWithPrimaryBenefits
3 entity
CY2023Q4 arkr Number Of Vi Es With Primary Benefits
NumberOfVIEsWithPrimaryBenefits
3 entity
CY2023Q4 arkr Lessee Operating Lease Notice To Vacate
LesseeOperatingLeaseNoticeToVacate
P12M
CY2023Q4 arkr Sales Tax Payable Current
SalesTaxPayableCurrent
1302000 usd
CY2023Q3 arkr Sales Tax Payable Current
SalesTaxPayableCurrent
765000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4140000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4487000 usd
CY2023Q4 arkr Contract With Customer Liability Customer Deposits
ContractWithCustomerLiabilityCustomerDeposits
3418000 usd
CY2023Q3 arkr Contract With Customer Liability Customer Deposits
ContractWithCustomerLiabilityCustomerDeposits
5962000 usd
CY2023Q4 arkr Accrued Occupancy And Other Operating Expenses Current
AccruedOccupancyAndOtherOperatingExpensesCurrent
2906000 usd
CY2023Q3 arkr Accrued Occupancy And Other Operating Expenses Current
AccruedOccupancyAndOtherOperatingExpensesCurrent
2615000 usd
CY2023Q4 arkr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
11766000 usd
CY2023Q3 arkr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
13829000 usd
CY2023Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
3454000 usd
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
3528000 usd
CY2023Q4 arkr Occupancy Lease Cost
OccupancyLeaseCost
122000 usd
CY2022Q4 arkr Occupancy Lease Cost
OccupancyLeaseCost
114000 usd
CY2023Q4 us-gaap Variable Lease Cost
VariableLeaseCost
1377000 usd
CY2022Q4 us-gaap Variable Lease Cost
VariableLeaseCost
1357000 usd
CY2023Q4 us-gaap Lease Cost
LeaseCost
4953000 usd
CY2022Q4 us-gaap Lease Cost
LeaseCost
4999000 usd
CY2023Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
4898000 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
5171000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y9M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.062
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
10450000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12881000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12143000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11960000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12057000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
6742000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
7222000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2011000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1987000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-82000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-95000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4649000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5140000 usd
CY2023Q4 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
285000 usd
CY2023Q4 arkr Paycheck Protection Program Loan Interest Forgiveness Income
PaycheckProtectionProgramLoanInterestForgivenessIncome
6000 usd
CY2022Q4 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
272000 usd
CY2022Q4 arkr Paycheck Protection Program Loan Interest Forgiveness Income
PaycheckProtectionProgramLoanInterestForgivenessIncome
6000 usd
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
304000 usd
CY2023Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
13000 usd
CY2022Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
542000 usd
CY2023Q4 arkr Number Of Stock Option Plans
NumberOfStockOptionPlans
2 plan
CY2023Q4 arkr Maximum Amount Of Compensation Paid Under Cash Bonus Plan
MaximumAmountOfCompensationPaidUnderCashBonusPlan
1000000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
471250 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.57
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
471250 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.57
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
308000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
310125 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.21
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M6D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
154000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
477500 shares
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
77000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
79000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
151000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
CY2023Q4 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
285000 usd
CY2022Q4 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
272000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.090
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114000 usd
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.053
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3604000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
27000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
48000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3631000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3648000 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
381250 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
418000 shares
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1875
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000779544-24-000017-index-headers.html Edgar Link pending
0000779544-24-000017-index.html Edgar Link pending
0000779544-24-000017.txt Edgar Link pending
0000779544-24-000017-xbrl.zip Edgar Link pending
arkr-20231230.htm Edgar Link pending
arkr-20231230.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q1-202410xqexhibit311.htm Edgar Link pending
q1-202410xqexhibit312.htm Edgar Link pending
q1-202410xqexhibit32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
arkr-20231230_def.xml Edgar Link unprocessable
arkr-20231230_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arkr-20231230_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
arkr-20231230_pre.xml Edgar Link unprocessable
arkr-20231230_cal.xml Edgar Link unprocessable